We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Uramin Inc | LSE:UMN | London | Ordinary Share | VGG9298V1067 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 389.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:5915C UraMin Inc 21 August 2007 Company: UraMin Inc TIDM: UMN Headline: CFMM Developpement becomes sole shareholder of UraMin Inc Released: 21 August 2007 CFMM DEVELOPPEMENT BECOMES SOLE SHAREHOLDER OF URAMIN INC AREVA today announces that its indirect wholly-owned subsidiary, CFMM Developpement, has become the sole shareholder of UraMin Inc ("UraMin" or "the Company") following the completion of compulsory redemption proceedings in accordance with the laws of the British Virgin Islands. As described in a notice sent to shareholders of UraMin on 7 August 2007, UraMin redeemed all of its issued and outstanding shares that were not held by AREVA for an amount equal to US$7.75 per share. That notice provides further information for former shareholders of UraMin seeking to receive the redemption price, which is held by Computershare Investor Services Inc as agent for UraMin. Any questions in this regard should be directed to Computershare Investor Services Inc at +1 (514) 982 7555 or by e-mail at corporateactions@computershare.com. In connection with the redemption, the shares of UraMin were delisted from the Toronto Stock Exchange on 20 August 2007. As previously announced, UraMin has also requested the cancellation of its listing on the Alternative Investment Market of the London Stock Exchange, which is expected to be effective on 4 September 2007. Forward Looking Statements: This announcement may include forward-looking statements. All statements other than statements of historical fact included in this announcement, including without limitation those regarding plans, objectives and expected performance, are forward-looking statements. These forward-looking statements are based on current expectations and projections about future events, including numerous assumptions regarding present and future business strategies, operations, and the environment in which the business will operate in the future. Forward-looking statements generally can be identified by the use of forward-looking terminology such as 'ambition', 'may', 'will', 'could', 'would', 'expect', 'intend', 'estimate', 'anticipate', 'believe', 'plan', 'seek' or 'continue', or negative forms or variations of similar terminology. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors. By their nature, forward-looking statements involve risks, uncertainties and assumptions, such as future market conditions and the behaviour of other market participants, which may cause the actual results, performance or achievements of UraMin to differ materially from any future results, performance or achievements expressed or implied by the forward looking statements. Given these risks, uncertainties, and assumptions, you are cautioned not to put undue reliance on any forward-looking statements. In addition, the inclusion of such forward-looking statements should under no circumstances be regarded as a representation that any results set out in such statements will be achieved or that the underlying assumptions used will in fact be the case. Other than as required by applicable law or the applicable rules of relevant exchanges, neither AREVA nor CFMM Developpement has any intention or obligation to update or revise any forward-looking statements included in this announcement after the release of this announcement. Further Information: AREVA Frederic Potelle Tel: +33 134 961 408 UraMin Inc Neil Herbert Tel: +27 11 783 5056 Canaccord Adams Limited (Nominated Adviser to UraMin Inc) Robin Birchall Tel: +44 20 7050 6500 END This information is provided by RNS The company news service from the London Stock Exchange END HOLUAVNRBBRWUAR
1 Year Uramin Chart |
1 Month Uramin Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions